Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHLEEN G ESSEL

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1831532019
CMS profile
3274263
Location
SYLVANIA, OH

General Payments · PY2019–2024

$965.25

  • Reported across 30 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$410.06

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $310.12 13
Education $99.94 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $176.70 4
EISAI INC. $87.71 3
Merck Sharp & Dohme Corporation $59.34 3
ABBVIE INC. $24.82 1
Astellas Pharma US Inc $24.44 1
GlaxoSmithKline, LLC. $18.79 1
VERTEX PHARMACEUTICALS INCORPORATED $18.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $338.92 4
PY2022 $182.34 10
PY2023 $33.93 2
PY2024 $410.06 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.82 07/17/2024 Food and Beverage Undisputed 01/23/2026 1103700078 CMS
Astellas Pharma US Inc $24.44 05/21/2024 Food and Beverage Undisputed 01/23/2026 1139349448 CMS
AstraZeneca Pharmaceuticals LP $25.55 03/12/2024 Food and Beverage Undisputed 01/23/2026 1105595091 CMS
AstraZeneca Pharmaceuticals LP $27.63 04/30/2024 Food and Beverage Undisputed 01/23/2026 1104317258 CMS
AstraZeneca Pharmaceuticals LP $23.58 05/15/2024 Food and Beverage Undisputed 01/23/2026 1104377637 CMS
AstraZeneca Pharmaceuticals LP $99.94 06/25/2024 Education Undisputed 01/23/2026 1104254047 CMS
Eisai Inc. $24.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 1110757634 CMS
Eisai Inc. $33.67 07/30/2024 Food and Beverage Undisputed 01/23/2026 1110757636 CMS
Eisai Inc. $30.04 09/30/2024 Food and Beverage Undisputed 01/23/2026 1110757632 CMS
GlaxoSmithKline, LLC. $18.79 01/23/2024 Food and Beverage Undisputed 01/23/2026 1116413337 CMS
Merck Sharp & Dohme LLC $26.56 02/20/2024 Food and Beverage Undisputed 01/23/2026 1141784693 CMS
Merck Sharp & Dohme LLC $17.36 08/06/2024 Food and Beverage Undisputed 01/23/2026 1141899724 CMS
Merck Sharp & Dohme LLC $15.42 09/17/2024 Food and Beverage Undisputed 01/23/2026 1141784701 CMS
VERTEX PHARMACEUTICALS INCORPORATED $18.26 11/26/2024 Food and Beverage Undisputed 01/23/2026 1105909970 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.